insights_auto
Why is AGIO down ၄.၀၃%?
Dive Deeperchevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
၂၇.၆၀ US$
arrow_downward
-၄.၀၃%(-၁.၁၆) 1D
၂၇.၆၀ US$
၀.၀၀% (၀.၀၀)
bedtimeAfter hours
Closed: နို ၂၀, GMT-၅ ၁၆:၀၀:၀၀ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
၂၈.၀၁ US$
High
၂၉.၁၄ US$
Low
၂၇.၄၃ US$
Mkt. cap
၁၆၅.၀၇ ဋေ
Avg. vol.
၁.၁၃ သန်း
Volume
၇.၇၆ သိန်း
52-wk high
၄၄.၀၇ US$
52-wk low
၂၃.၀၂ US$
EPS
-၆.၃၂ US$
Beta
၀.၆၆
Shares outstanding
၅.၉၈ ကုဋေ
No. of employees
၅၄၀
Open
၂၈.၀၁ US$
High
၂၉.၁၄ US$
Low
၂၇.၄၃ US$
Mkt. cap
၁၆၅.၀၇ ဋေ
Avg. vol.
၁.၁၃ သန်း
Volume
၇.၇၆ သိန်း
52-wk high
၄၄.၀၇ US$
52-wk low
၂၃.၀၂ US$
EPS
-၆.၃၂ US$
Beta
၀.၆၆
Shares outstanding
၅.၉၈ ကုဋေ
No. of employees
၅၄၀
News stories
From web sources and news partners
BeInCrypto
·
ပြီးခဲ့သည့် ၁၀ နာရီ
China, Korea and Taiwan Rush Stock Rescues Before Monday: Can They Help the S&P 500?
Bloomberg.com
·
ပြီးခဲ့သည့် ၂ နာရီ
S&P 500 at 5,600? Crushing China’s AI Ambitions Has a Price
Crypto Briefing
·
ပြီးခဲ့သည့် ၄ နာရီ
Nasdaq slides deeper as Nvidia rout drags S&P 500 and Dow into correction
cwibc.co.id
·
ပြီးခဲ့သည့် ၁ နာရီ
S&P 500 Faces Thanksgiving Week After Sharp Market Selloff
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc